- Home
- PRFX vs YCBD Comparison
PRFX vs YCBD Comparison
Compare PRFX & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRFX
- YCBD
- Stock Information
- Founded
- PRFX 2007
- YCBD 2015
- Country
- PRFX Israel
- YCBD United States
- Employees
- PRFX N/A
- YCBD N/A
- Industry
- PRFX Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- PRFX Health Care
- YCBD Health Care
- Exchange
- PRFX Nasdaq
- YCBD Nasdaq
- Market Cap
- PRFX 3.0M
- YCBD 3.2M
- IPO Year
- PRFX 2020
- YCBD N/A
- Fundamental
- Price
- PRFX $3.16
- YCBD $0.45
- Analyst Decision
- PRFX Hold
- YCBD
- Analyst Count
- PRFX 1
- YCBD 0
- Target Price
- PRFX N/A
- YCBD N/A
- AVG Volume (30 Days)
- PRFX 3.2M
- YCBD 2.0M
- Earning Date
- PRFX 01-01-0001
- YCBD 02-13-2025
- Dividend Yield
- PRFX N/A
- YCBD N/A
- EPS Growth
- PRFX N/A
- YCBD N/A
- EPS
- PRFX N/A
- YCBD N/A
- Revenue
- PRFX N/A
- YCBD $19,220,238.00
- Revenue This Year
- PRFX N/A
- YCBD $13.00
- Revenue Next Year
- PRFX N/A
- YCBD $10.00
- P/E Ratio
- PRFX N/A
- YCBD N/A
- Revenue Growth
- PRFX N/A
- YCBD N/A
- 52 Week Low
- PRFX $0.43
- YCBD $0.31
- 52 Week High
- PRFX $16.63
- YCBD $1.34
- Technical
- Relative Strength Index (RSI)
- PRFX 49.34
- YCBD 42.04
- Support Level
- PRFX $3.22
- YCBD $0.42
- Resistance Level
- PRFX $5.47
- YCBD $0.69
- Average True Range (ATR)
- PRFX 0.34
- YCBD 0.06
- MACD
- PRFX 0.04
- YCBD -0.02
- Stochastic Oscillator
- PRFX 15.97
- YCBD 10.98
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.